Physical Therapists in Rector, AR Accepting Medicare
1 Physical Therapists found. Showing 1 - 1
 Amy Manchester Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1009 W 5th St, Rector, AR 72461 Phone: 870-930-6269 |
News Archive
Climate change can harm indigenous peoples' health
The Canadian Arctic. The Amazonian jungle. The fringes of an African rainforest. These lands are home to some of the most isolated and vulnerable people in the world - the indigenous populations of Canada, Peru and Uganda. Because of their dependence on the land for food and water, indigenous peoples' health is particularly affected by climatic changes. Indeed, they are already seeing dramatic effects due to changing temperatures.
Researchers develop way to adjust BMI values for children of different ethnicities
BMI is the most widely-used measure of obesity in children, but the existing 'one-size fits all' standards don't provide accurate readings for UK South Asian or Black African children.c
GMP protein can improve gastrointestinal health by protecting digestive system from pathogens
The protein glycomacropeptide (GMP) is derived from whey, the liquid by-product of the cheese-making process. GMP contains low amounts of the amino acid phenylalanine. Individuals who suffer from phenylketonuria—a metabolic disorder that causes cognitive impairment when phenylalanine level is too high—can use GMP as an alternative protein source. GMP supplementation has also been observed to improve gastrointestinal health by protecting the digestive system from pathogens and by having an anti-inflammatory effect.
Genervon completes GM604 Phase 2a clinical trial for amyotrophic lateral sclerosis
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
RPCI researchers identify two novel candidate prognostic markers for ovarian cancer
Cancer researchers at Roswell Park Cancer Institute have identified two independent classes of novel candidate prognostic markers for ovarian cancer, advancing efforts to develop targeted therapies for the disease. The findings resulted from two separate studies published in the peer-reviewed journal PLoS ONE and based on data from The Cancer Genome Atlas (TCGA), the world's largest public database on gene expression in different tumor types.
› Verified 5 days ago